 | • レポートコード：MRC2-11QY12498 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は悪性黒子型黒色腫治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、免疫療法、標的療法、放射線療法）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別悪性黒子型黒色腫治療薬の競争状況、市場シェア ・世界の悪性黒子型黒色腫治療薬市場：種類別市場規模 2015年-2020年（化学療法、免疫療法、標的療法、放射線療法） ・世界の悪性黒子型黒色腫治療薬市場：種類別市場規模予測 2021年-2026年（化学療法、免疫療法、標的療法、放射線療法） ・世界の悪性黒子型黒色腫治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の悪性黒子型黒色腫治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の悪性黒子型黒色腫治療薬市場分析：米国、カナダ ・ヨーロッパの悪性黒子型黒色腫治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの悪性黒子型黒色腫治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の悪性黒子型黒色腫治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの悪性黒子型黒色腫治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Chiron Corporation、Amgen、Bristol-Myers Squibb、Merck & Co、Novartis、Roche ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lentigo maligna is a subtype of melanoma in situ that is characterized by an atypical proliferation of melanocytes within the basal epidermis; lentigo maligna that invades the dermis is termed lentigo maligna melanoma.
Market Analysis and Insights: Global Lentigo Maligna Melanoma Therapeutic Market
The global Lentigo Maligna Melanoma Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lentigo Maligna Melanoma Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lentigo Maligna Melanoma Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lentigo Maligna Melanoma Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lentigo Maligna Melanoma Therapeutic market.
Global Lentigo Maligna Melanoma Therapeutic Scope and Market Size
Lentigo Maligna Melanoma Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lentigo Maligna Melanoma Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Chemotherapy
Immunotherapy
Targeted Therapy
Radiation Therapy
Market segment by Application, split into
Hospital
Clinic
Other
Based on regional and country-level analysis, the Lentigo Maligna Melanoma Therapeutic market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Lentigo Maligna Melanoma Therapeutic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Chiron Corporation
Amgen
Bristol-Myers Squibb
Merck & Co
Novartis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lentigo Maligna Melanoma Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Radiation Therapy
1.3 Market by Application
1.3.1 Global Lentigo Maligna Melanoma Therapeutic Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lentigo Maligna Melanoma Therapeutic Market Perspective (2015-2026)
2.2 Global Lentigo Maligna Melanoma Therapeutic Growth Trends by Regions
2.2.1 Lentigo Maligna Melanoma Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lentigo Maligna Melanoma Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lentigo Maligna Melanoma Therapeutic Players by Market Size
3.1.1 Global Top Lentigo Maligna Melanoma Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share by Players (2015-2020)
3.2 Global Lentigo Maligna Melanoma Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lentigo Maligna Melanoma Therapeutic Revenue
3.4 Global Lentigo Maligna Melanoma Therapeutic Market Concentration Ratio
3.4.1 Global Lentigo Maligna Melanoma Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lentigo Maligna Melanoma Therapeutic Revenue in 2019
3.5 Key Players Lentigo Maligna Melanoma Therapeutic Area Served
3.6 Key Players Lentigo Maligna Melanoma Therapeutic Product Solution and Service
3.7 Date of Enter into Lentigo Maligna Melanoma Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lentigo Maligna Melanoma Therapeutic Breakdown Data by Type (2015-2026)
4.1 Global Lentigo Maligna Melanoma Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Type (2021-2026)
5 Lentigo Maligna Melanoma Therapeutic Breakdown Data by Application (2015-2026)
5.1 Global Lentigo Maligna Melanoma Therapeutic Historic Market Size by Application (2015-2020)
5.2 Global Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lentigo Maligna Melanoma Therapeutic Market Size (2015-2026)
6.2 North America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020)
6.3 North America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020)
6.4 North America Lentigo Maligna Melanoma Therapeutic Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Lentigo Maligna Melanoma Therapeutic Market Size (2015-2026)
7.2 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020)
7.3 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020)
7.4 Europe Lentigo Maligna Melanoma Therapeutic Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Lentigo Maligna Melanoma Therapeutic Market Size (2015-2026)
8.2 China Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020)
8.3 China Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020)
8.4 China Lentigo Maligna Melanoma Therapeutic Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Lentigo Maligna Melanoma Therapeutic Market Size (2015-2026)
9.2 Japan Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020)
9.3 Japan Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020)
9.4 Japan Lentigo Maligna Melanoma Therapeutic Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size (2015-2026)
10.2 Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020)
10.3 Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020)
10.4 Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Chiron Corporation
11.1.1 Chiron Corporation Company Details
11.1.2 Chiron Corporation Business Overview
11.1.3 Chiron Corporation Lentigo Maligna Melanoma Therapeutic Introduction
11.1.4 Chiron Corporation Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020))
11.1.5 Chiron Corporation Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Lentigo Maligna Melanoma Therapeutic Introduction
11.2.4 Amgen Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
11.2.5 Amgen Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Lentigo Maligna Melanoma Therapeutic Introduction
11.3.4 Bristol-Myers Squibb Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Lentigo Maligna Melanoma Therapeutic Introduction
11.4.4 Merck & Co Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
11.4.5 Merck & Co Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Lentigo Maligna Melanoma Therapeutic Introduction
11.5.4 Novartis Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
11.5.5 Novartis Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Lentigo Maligna Melanoma Therapeutic Introduction
11.6.4 Roche Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
11.6.5 Roche Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lentigo Maligna Melanoma Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Radiation Therapy
Table 7. Global Lentigo Maligna Melanoma Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Lentigo Maligna Melanoma Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Lentigo Maligna Melanoma Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Lentigo Maligna Melanoma Therapeutic Market Share by Regions (2015-2020)
Table 11. Global Lentigo Maligna Melanoma Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Lentigo Maligna Melanoma Therapeutic Market Share by Regions (2021-2026)
Table 13. Lentigo Maligna Melanoma Therapeutic Market Market Trends
Table 14. Lentigo Maligna Melanoma Therapeutic Market Drivers
Table 15. Lentigo Maligna Melanoma Therapeutic Market Challenges
Table 16. Lentigo Maligna Melanoma Therapeutic Market Restraints
Table 17. Global Lentigo Maligna Melanoma Therapeutic Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Lentigo Maligna Melanoma Therapeutic Market Share by Players (2015-2020)
Table 19. Global Top Lentigo Maligna Melanoma Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lentigo Maligna Melanoma Therapeutic as of 2019)
Table 20. Global Lentigo Maligna Melanoma Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lentigo Maligna Melanoma Therapeutic Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Lentigo Maligna Melanoma Therapeutic Market Size Share by Type (2015-2020)
Table 26. Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share by Type (2021-2026)
Table 27. Global Lentigo Maligna Melanoma Therapeutic Market Size Share by Application (2015-2020)
Table 28. Global Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Lentigo Maligna Melanoma Therapeutic Market Size Share by Application (2021-2026)
Table 30. North America Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Lentigo Maligna Melanoma Therapeutic Market Share by Type (2015-2020)
Table 32. North America Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Lentigo Maligna Melanoma Therapeutic Market Share by Application (2015-2020)
Table 34. North America Lentigo Maligna Melanoma Therapeutic Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Lentigo Maligna Melanoma Therapeutic Market Share by Country (2015-2020)
Table 36. Europe Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Lentigo Maligna Melanoma Therapeutic Market Share by Type (2015-2020)
Table 38. Europe Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Lentigo Maligna Melanoma Therapeutic Market Share by Application (2015-2020)
Table 40. Europe Lentigo Maligna Melanoma Therapeutic Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Lentigo Maligna Melanoma Therapeutic Market Share by Country (2015-2020)
Table 42. China Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 43. China Lentigo Maligna Melanoma Therapeutic Market Share by Type (2015-2020)
Table 44. China Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 45. China Lentigo Maligna Melanoma Therapeutic Market Share by Application (2015-2020)
Table 46. China Lentigo Maligna Melanoma Therapeutic Market Size by Region (US$ Million) (2015-2020)
Table 47. China Lentigo Maligna Melanoma Therapeutic Market Share by Region (2015-2020)
Table 48. Japan Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Lentigo Maligna Melanoma Therapeutic Market Share by Type (2015-2020)
Table 50. Japan Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Lentigo Maligna Melanoma Therapeutic Market Share by Application (2015-2020)
Table 52. Japan Lentigo Maligna Melanoma Therapeutic Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Lentigo Maligna Melanoma Therapeutic Market Share by Country (2015-2020)
Table 54. Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Share by Type (2015-2020)
Table 56. Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Share by Application (2015-2020)
Table 58. Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Share by Country (2015-2020)
Table 60. Chiron Corporation Company Details
Table 61. Chiron Corporation Business Overview
Table 62. Chiron Corporation Product
Table 63. Chiron Corporation Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020) (US$ Million)
Table 64. Chiron Corporation Recent Development
Table 65. Amgen Company Details
Table 66. Amgen Business Overview
Table 67. Amgen Product
Table 68. Amgen Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020) (US$ Million)
Table 69. Amgen Recent Development
Table 70. Bristol-Myers Squibb Company Details
Table 71. Bristol-Myers Squibb Business Overview
Table 72. Bristol-Myers Squibb Product
Table 73. Bristol-Myers Squibb Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020) (US$ Million)
Table 74. Bristol-Myers Squibb Recent Development
Table 75. Merck & Co Company Details
Table 76. Merck & Co Business Overview
Table 77. Merck & Co Product
Table 78. Merck & Co Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020) (US$ Million)
Table 79. Merck & Co Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Product
Table 83. Novartis Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020) (US$ Million)
Table 84. Novartis Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Product
Table 88. Roche Revenue in Lentigo Maligna Melanoma Therapeutic Business (2015-2020) (US$ Million)
Table 89. Roche Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lentigo Maligna Melanoma Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Immunotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Radiation Therapy Features
Figure 6. Global Lentigo Maligna Melanoma Therapeutic Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Lentigo Maligna Melanoma Therapeutic Report Years Considered
Figure 11. Global Lentigo Maligna Melanoma Therapeutic Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Lentigo Maligna Melanoma Therapeutic Market Share by Regions: 2020 VS 2026
Figure 13. Global Lentigo Maligna Melanoma Therapeutic Market Share by Regions (2021-2026)
Figure 14. Global Lentigo Maligna Melanoma Therapeutic Market Share by Players in 2019
Figure 15. Global Top Lentigo Maligna Melanoma Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lentigo Maligna Melanoma Therapeutic as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Lentigo Maligna Melanoma Therapeutic Revenue in 2019
Figure 17. North America Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Lentigo Maligna Melanoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Chiron Corporation Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
Figure 45. Amgen Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
Figure 47. Merck & Co Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
Figure 48. Novartis Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
Figure 49. Roche Revenue Growth Rate in Lentigo Maligna Melanoma Therapeutic Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
黒色腫の世界市場（～2026年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…- リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
- 非黒色腫皮膚がんの世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 非黒色腫皮膚がん治療の世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 白血病治療の世界市場（～2026年） Leukemia is a type of cancer which is formed in blood tissues. Leukemia occurs in bone marrow which is a soft tissue. Leukemia develops by the uncontrolled growth of blood cells in the bone marrow. Leukemia is also defined as a cancer of white blood cells. Leukemia therapeutics consists of three ste…